Bonerge Lifescience is a leading provider of premium-quality ingredients for the pharmaceutical, food, and cosmeceutical industries. With a strong commitment to safety, quality, and sustainability, the company focuses on harnessing nature's potential to deliver innovative health solutions.

In 2023, Bonerge expanded its capabilities with the opening of a cutting-edge manufacturing facility in Hunan, China. This 70,000-square-meter facility is equipped with state-of-the-art technology and adheres to international quality standards, ensuring the production of safe and effective ingredients.

Bonerge's product lineup features branded ingredients such as BeFisetin® (Fisetin), UroAce® (Urolithin A), GlucoSober® (Dihydroberberine), and NADHelp+® (NMNH). These ingredients are designed to promote healthy ageing and overall well-being by targeting key cellular processes.

Driven by continuous innovation, Bonerge aims to support global health by delivering high-quality, science-backed solutions that cater to the evolving demands of the wellness industry.